Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 482-330-9 | CAS number: 144020-22-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental toxico-kinetic data are available for assessing adsorption, distribution, metabolism and excretion of the substance. Based on effects seen in the human health toxicity studies and physico-chemical parameters the substance is expected to be readily absorbed via the oral and inhalation route and somewhat lower via the dermal route. Using the precautionary principle for route-to-route extrapolation the final absorption percentages derived are: 50% oral absorption, 50% dermal absorption and 100% inhalation absorption.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Short key information
No experimental toxico-kinetic data are available for assessing adsorption, distribution, metabolism and excretion of the substance. Based on effects seen in the human health toxicity studies and physico-chemical parameters the substance is expected to be readily absorbed via the oral and inhalation route and somewhat lower via the dermal route. Using the precautionary principle for route-to-route extrapolation the final absorption percentages derived are: 50% oral absorption, 50% dermal absorption and 100% inhalation absorption.
Toxico-kinetic behaviour of substance Trimofix O
Introduction
Trimofix O (Cas no 144020-22-4) is an organic UVCB substance called Reaction products of acetic anhydride and of 1,5,10-trimethyl 1,5,9-cyclodecatriene. One constituent has a cyclododecadiene ring with two methyl groups, an acetyl and a methylene group attached to it and has exocyclic double bond (structure no 1). The second one has a cyclododecatriene ring with three methyl groups and an acetyl group attached to the ring. The 3rd constituent is similar to the 2nd one but has a conjugated bond with the acetyl group (see Fig. 1). Trimofix O is clear liquid with a molecular weight of 246 that does not preclude absorption. The substance has a volatility of 0.06 Pa at 25°C, water solubility of 4.8 mg/L at 20°C and a Log Kow of 5.55 (at 25°C and 7 ≥ pH ≤ 7.3). According to Belsito et al. (2013) Trimofix O belongs to the diverse group unsaturated alkyl cyclic ketones in which either the alkyl or cyclic portion of the molecule has at least one double bond.
Absorption, oral: The results of the repeat dose oral toxicity of Trimofix O show that the substance is being absorbed by the gastro-intestinal tract following oral administration, because increased liver weights were seen. The relatively low molecular weight and the high octanol/water partition coefficient (Log Kow 5.5) and water solubility (4.8 mg/l) would favour absorption through the gut. According to Martinez and Amidon (2002) the optimal log Kow for oral absorption falls within a range of 2-7. This shows that the substance is likely to be absorbed orally and therefore the oral absorption is expected to be > 50%.
Absorption, skin: Based on the physico-chemical characteristics of the substance, being a liquid, its molecular weight (246), log Kow (5.55) and water solubility (4.8 mg/L), indicate that (some) dermal absorption is likely to occur. The molecular weight lies outside the optimum of < 100 as well as its log Kow (ECHA guidance, 7.12, Table R.7.12-3). (log Kow 1-4), The substance is considered to be not irritating to skin and is classified as a skin sensitiser, which indicates that (some) dermal absorption occurs.
Absorption, lungs: Absorption via the lungs is also indicated based on physico-chemical properties. Though the inhalation exposure route is thought minor, because its low volatility (0.06 Pa), the octanol/water partition coefficient (5.55), indicates that inhalation absorption is possible.
The blood/air (BA) partition coefficient is another partition coefficient indicating lung absorption: Buist et al. 2012 have developed BA model for humans using the most important and readily available parameters:
Log PBA = 6.96 – 1.04 Log (VP) – 0.533 (Log) Kow – 0.00495 MW.
For Trimofix the B/A partition coefficient would result in:
Log P (BA) = 6.96 – 1.04 (-1.22) – 0.533 x 5.55 – 0.00495 x 246 = 4.04
This means that the substance has a tendency to go from air into the blood. It should, however, be noted that this regression line is only valid for substances which have a vapour pressure > 100 Pa. Despite the substance being somewhat out of the applicability domain and the exact B/A may not be fully correct, it can be seen that the substance will be readily absorbed via the inhalation route and will be close to 100%.
Distribution: The moderate water solubility of the test substance would limit distribution in the body via the water channels. The log Kow suggest that the substance would pass through the biological cell membrane. The absence of bioaccumulation in fish indicates that the substance will not bioaccumulate and is metabolised significantly. Due to the expected metabolism the substance as such would not accumulate in the body fat.
Metabolism: There are no actual data on the metabolism of the substance. The OECD Toolbox (4.4.1) predicts over 50 metabolites. According to Belsito et al. 2013 structurally complex molecules with multiple functionalities, such as the ACK fragrance ingredients, rarely undergo a single primary metabolism pathway. During phase 1 the predominant primary metabolic pathway is the reduction of the ketone by alcohol dehydrogenases and the hydroxylation of the double bonds.). During Phase II the alcohols will be conjugated with glucuronic acid and excreted (Belsito, 2013).
Excretion: The metabolic profile and molecular weight indicate that a route of excretion is through the urine. Any unabsorbed substance will be excreted via the faeces.
Discussion
The substance is expected to be readily absorbed, orally and via inhalation, based on the human toxicological information and physico-chemical parameters. The substance also is expected to be absorbed dermally based on the physic-chemical properties. The MW and the log Kow are higher than the favourable range for dermal absorption but significant absorption is likely. The IGHRC (2006) document of the HSE and mentioned in the ECHA guidance Chapter 8 will be followed to derive the final absorption values for the risk characterisation.
Oral to dermal extrapolation
There are adequate data via the oral route and the critical toxic effect is related to systemic effects and therefore route to route extrapolation is applicable. The toxicity of the substance will be due to the parent compound but also to its metabolites. The overriding principle will be to avoid situations where the extrapolation of data would underestimate toxicity resulting from human exposure to a chemical by the route-to-route extrapolation. The toxicity of the dermal route will not be underestimated because absorption will be slower and the compound will also pass the liver. Therefore, it will be assumed that the oral absorption will equal dermal absorption.
Oral to inhalation extrapolation
Though the substance is not a volatile liquid the inhalation exposure will be considered. The substance is not corrosive for skin and eye and the systemic effect will overrule the effects at the site of contact. In the absence of bioavailability data it is most precautionary that 100% of the inhaled vapour is bioavailable. For the oral absorption 50% has been used for route-to-route extrapolation to be precautionary for the dermal route. For inhalation absorption 100% will be used for route-to-route extrapolation, because this will be precautionary for the inhalation route.
Conclusion
The substance is expected to be readily absorbed via the oral, dermal and inhalation route based on toxicity and physico-chemical data. Using the precautionary principle for route-to-route extrapolation the final absorption percentages derived are: 50% oral absorption, 50% dermal absorption and 100% inhalation absorption.
References
Belsito, D., Bickers, D., Bruze, M., Calow, P., Dagli, M.L., Fryer, A.D., Greim, H., Miyachi, Y., Saurat, J.H., Sipes, I.G., 2013, A toxicological and dermatological assessment of alkyl cyclic ketones when used as fragrance ingredients, Food and Chemical Toxicology, 62, S1-S44.
Buist, H.E., Wit-Bos de, L., Bouwman, T., Vaes, W.H.J., 2012, Predicting blood:air partion coefficient using basis physico-chemical properties, Regul. Toxicol. Pharmacol., 62, 23-28.
IGHRC, 2006, Guidelines on route to route extrapolation of toxicity data when assessing health risks of chemicals, http://www.iehconsulting.co.uk/IEH_Consulting/IEHCPubs/IGHRC/cr12.pdf
Martinez, M.N., And Amidon, G.L., 2002, Mechanistic approach to understanding the factors affecting drug absorption: a review of fundament, J. Clinical Pharmacol., 42, 620-643.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.